The purpose of the Committee on Biologics is to monitor 1) new developments in veterinary biologics, 2) regulation of the manufacture, distribution and use of veterinary biologics, and 3) needs of the livestock industries for new biological products. Committee action may be in the form of recommendations to the President for action or, in the case of major issues, resolutions to be considered by the General Session.
The purpose of the Committee on Biotechnology is to provide a forum at USAHA meetings and elsewhere as directed for State, Federal, University, private industry, and citizens-at-large to focus on issues and developments in the field of biotechnology as related to animals. The Committee reviews and discusses regulations and guidelines that are in preparation or have been issued at the National, State or international level in an attempt to regulate developments in the field which are designed to provide protection to man, animals, and the environment. Biotechnology has profound economic implications, brought about by developments of totally new products or processes. The Committee has the responsibility to keep abreast of these changes and advise USAHA relative to impact on the U.S. livestock industry.
Resolution 26: Manufacturing of Veterinary Biologicals without Licensure
Resolution 33: UPDATING ANTIQUATED TESTING REQUIREMENTS FOR ANIMALS USED IN THE PRODUCTION OF LICENSED SERUM ANTIBODY PRODUCTS
Resolution 32: Funding for New Facility Operations at the National Centers for Animal Health
Resolution 15: Funding for the USDA—AHPIS—VS Center for Veterinary Biologics
Resolution 13: Importation of Fetal Bovine Serum
Resolution 20: USDA Jurisdiction for Animal Disease Vaccines That Also Have a Public Health Benefit